Piperidine → N-(5-methyl-1H-pyrazol-3-yl)-6-(piperidin-1-yl)-2-styrylpyrimidin-4-amine
반응식
[C:1](#[N:10])[CH:2]=[CH:3][C:4]1[CH:9]=[CH:8][CH:7]=[CH:6][CH:5]=1.[CH3:11][C:12]1[NH:16][N:15]=[C:14]([NH2:17])[CH:13]=1.[NH:18]1[CH2:23][CH2:22][CH2:21][CH2:20][CH2:19]1>>[CH3:11][C:12]1[NH:16][N:15]=[C:14]([NH:17][C:3]2[CH:2]=[C:1]([N:18]3[CH2:23][CH2:22][CH2:21][CH2:20][CH2:19]3)[N:10]=[C:1]([CH:2]=[CH:3][C:4]3[CH:9]=[CH:8][CH:7]=[CH:6][CH:5]=3)[N:10]=2)[CH:13]=1참가 물질
4
실험 절차
Example 67 was synthesized via Scheme 6 according to the general scheme provided above with the appropriate starting materials cinnamonitrile, 5-methyl-1H-pyrazole-3-amine, and piperidine. Structure of the target was confirmed by 1H-NMR. The 1H-NMR is attached.
후처리
- customExample 67 was synthesized via Scheme 6 according to the general scheme
- customprovided above with the
출처 및 근거
- ORD 기록
- ord-00dbd1e402c94f5c9babd78eacd99ff0
- 출처 데이터셋
- uspto-grants-2012_02
- 특허 번호
- US08114870B2
반응 노트
불러오는 중…